Stevens-Johnson Syndrome Caused by Enzalutamide: A Case Report and Literature Review

Stevens-Johnson Syndrome Caused by Enzalutamide: A Case Report and Literature Review

ObjectiveEnzalutamide is the most frequently prescribed compound for treating metastatic castration-resistant prostate cancer (mCRPC). Common adverse drug events of enzalutamide are febrile neutropenia, hot flashes, hypertension, and fatigue.MethodsWe present a case of a patient with mCRPC who recei...

Full description

Bibliographic Details
Main Authors: Min Deng, Huirong Chai, Meng Yang, Xueman Wei, Wenjun Zhang, Xuebin Wang, Juanjuan Li, Zhuo Wang, Haitao Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Oncology
Subjects:
enzalutamide
Stevens-Johnson syndrome
drug eruption
cutaneous adverse events
prostate cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.736975/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.736975/full

Similar Items